Moreover, silencing KIF2A reduces cell proliferation and migration, enhances cell apoptosis, and induces G2/M phase arrest through inhibiting PI3K/AKT and MAPK/ERK pathways in lung adenocarcinoma cells (11). The gene discussed is AKT1; the disease is lung adenocarcinoma.